[ad_1]
Sydney, Feb. 01, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
- Perpetual Resources Ltd (ASX:PEC) is advancing the pre-feasibility study update (PFSU) for its Beharra Project in Western Australia to assess the economic viability of bulk white sand extraction following successful metallurgical test-work. Click here
- Northern Minerals Ltd (ASX:NTU) has launched a strategic review of its business holdings and activities after appointing new chair Nick Curtis to the board, temporarily pausing a planned feasibility study for the Browns Range Heavy Rare Earth Project in Western Australia in order to include it in the review process. Click here
- Orthocell Ltd (ASX:OCC) enters 2022 with a strong balance sheet, a balance cash of A$13.6 million at the end of the December quarter and sufficient funds to support key regulatory approvals and commercialisation goals. Click here
- Australian Strategic Materials Ltd (ASX:ASM) ended the December quarter in a strong financial position, well-funded with A$56.9 million in cash as it advances its critical metal assets across Australia and South Korea. Click here
- South Harz Potash Ltd (ASX:SHP) has strengthened its presence in the region of Germany that hosts its flagship South Harz Potash Project through the appointment of Dr Babette Winter as regional manager Thŭringia. Click here
- AVZ Minerals Ltd (ASX:AVZ) has turned its attention to infrastructure for the Manono Lithium and Tin Project in the Democratic Republic of Congo (DRC) as the company awaits approval for a mining licence for the tenure preparing, following an oversubscribed $75 million placement and AVZ’s entry into the new DRC Battery Council. Click here
- Matador Mining Ltd ((ASX:MZZ, OTCQX:MZZMF) has appointed a new CEO after rounding out 2021 with the largest-ever annual exploration campaign at the Cape Ray Gold Project in Newfoundland, Canada. Click here
- Element 25 Ltd (ASX:E25) delivered a daily production record of 1,209 tonnes of concentrate in early January from its Butcherbird Manganese Project which comes on top of a robust December quarter. Click here
- Chimeric Therapeutics Ltd (ASX:CHM) has signed a sponsored research agreement with the University of Pennsylvania to support the continued research and development of CHM 2101, a novel third-generation CDH17 CAR T cell therapy. Click here
- Archer Materials…
Full story available on Benzinga.com
[ad_2]
Source link
